{"transactions":[{"id":927102,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":68398,"kind":"person","name":"Slover Peter T","position":1,"cik":"0001468012","reported_name":"Slover Peter T","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-30T21:57:46.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":192000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options granted under the Issuer's 2024 Equity Incentive Plan. The options shares vest in equal monthly installments over 48 months, subject to the Reporting Person's continuous service."}],"balance_after":192000,"derivative":{"exercise_price":14.26,"expiration_date":"2036-01-29","underlying":"Class A Common Stock","underlying_shares":192000},"source":{"system":"sec-edgar","filing":"0001437749-26-002578","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000143774926002578/rdgdoc.xml","form_type":"4"}},{"id":1289680,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":68398,"kind":"person","name":"Slover Peter T","position":1,"cik":"0001468012","reported_name":"Slover Peter T","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-31T21:40:30.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options granted under the Issuer's 2024 Equity Incentive Plan. 25% of the option shares vest on January 1, 2026 and the remainder vests in equal monthly installments over the next 36 months thereafter, subject to the Reporting Person's continuous service."}],"balance_after":110000,"derivative":{"exercise_price":9.79,"expiration_date":"2035-01-30","underlying":"Class A Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001437749-25-002435","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000143774925002435/rdgdoc.xml","form_type":"4"}},{"id":1499285,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":68398,"kind":"person","name":"Slover Peter T","position":1,"cik":"0001468012","reported_name":"Slover Peter T","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-05-29T21:58:54.000Z","date":"2024-05-24","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options granted under the Issuer's 2024 Equity Incentive Plan. 25% of the option shares vest on April 5, 2025, and the remainder vests in equal monthly installments over the next 36 months thereafter, subject to the Reporting Person's continuous service."}],"balance_after":100000,"derivative":{"exercise_price":15.76,"expiration_date":"2034-05-23","underlying":"Class A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-24-018625","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000143774924018625/rdgdoc.xml","form_type":"4"}},{"id":3332731,"issuer":{"id":152909,"kind":"organization","name":"SOPHIRIS BIO INC.","symbol":"SPHS"},"owners":[{"id":68398,"kind":"person","name":"Slover Peter T","position":1,"cik":"0001468012","reported_name":"Slover Peter T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock (Right to Buy)","published_at":"2019-12-23T16:13:39.000Z","date":"2019-12-19","kind":"grant","acquired":true,"shares":103000,"price":0.36,"value":37080.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33% of the shares subject to the option shall vest one year after the date of grant.  The remainder shall vest monthly thereafter over the next two years until fully vested on December 19, 2022."}],"balance_after":103000,"derivative":{"exercise_price":0.36,"exercise_date":"2020-12-19","expiration_date":"2029-12-18","underlying":"Common Stock","underlying_shares":103000},"source":{"system":"sec-edgar","filing":"0001209191-19-061781","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468012/000120919119061781/doc4.xml","form_type":"4"}},{"id":3708689,"issuer":{"id":152909,"kind":"organization","name":"SOPHIRIS BIO INC.","symbol":"SPHS"},"owners":[{"id":68398,"kind":"person","name":"Slover Peter T","position":1,"cik":"0001468012","reported_name":"Slover Peter T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock (Right to Buy)","published_at":"2019-01-03T16:28:45.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":205667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33% of the shares subject to the option shall vest on December 21, 2019. The remainder shall vest monthly thereafter over the next two years until fully vested on December 21, 2021."}],"balance_after":205667,"derivative":{"exercise_price":0.83,"exercise_date":"2019-12-21","expiration_date":"2028-12-30","underlying":"Common Stock","underlying_shares":205667},"source":{"system":"sec-edgar","filing":"0001209191-19-000970","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468012/000120919119000970/doc4.xml","form_type":"4"}},{"id":4137911,"issuer":{"id":152909,"kind":"organization","name":"SOPHIRIS BIO INC.","symbol":"SPHS"},"owners":[{"id":68398,"kind":"person","name":"Slover Peter T","position":1,"cik":"0001468012","reported_name":"Slover Peter T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock (Right to Buy)","published_at":"2017-12-08T16:23:57.000Z","date":"2017-12-06","kind":"grant","acquired":true,"shares":12768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33% of the shares subject to the option shall vest one year after the date of grant. The remainder shall vest monthly thereafter over the next two years until fully vested on December 6, 2020."}],"balance_after":12768,"derivative":{"exercise_price":1.91,"exercise_date":"2018-12-06","expiration_date":"2027-12-05","underlying":"Common Stock","underlying_shares":12768},"source":{"system":"sec-edgar","filing":"0001209191-17-064705","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468012/000120919117064705/doc4.xml","form_type":"4"}},{"id":4527059,"issuer":{"id":152909,"kind":"organization","name":"SOPHIRIS BIO INC.","symbol":"SPHS"},"owners":[{"id":68398,"kind":"person","name":"Slover Peter T","position":1,"cik":"0001468012","reported_name":"Slover Peter T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock (Right to Buy)","published_at":"2016-12-09T16:10:11.000Z","date":"2016-12-07","kind":"grant","acquired":true,"shares":154000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33% of the shares subject to the option shall vest one year after the date of grant.  The remainder shall vest monthly thereafter over the next two years until fully vested on December 7, 2019."}],"balance_after":154000,"derivative":{"exercise_price":2.74,"exercise_date":"2017-12-07","expiration_date":"2026-12-06","underlying":"Common Stock","underlying_shares":154000},"source":{"system":"sec-edgar","filing":"0001209191-16-154380","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468012/000120919116154380/doc4.xml","form_type":"4"}}]}